Number of immune-related adverse events hospitalizations with administration of immunosuppressants
| Immunosuppressant | Number of hospitalizations |
| Prednisone | 454 (71.8%) |
| Methylprednisolone | 160 (25.3%) |
| Mycophenolate | 5 (0.8%) |
| Tacrolimus | 3 (0.5%) |
| Cyclosporine | 2 (0.3%) |
| Everolimus | 2 (0.3%) |
| Infliximab | 2 (0.3%) |
| Sirolimus | 2 (0.3%) |
| Azathioprine | 1 (0.2%) |
| Methotrexate | 1 (0.2%) |
| Basiliximab | 0 |
| IVIG | 0 |
| Leflunomide | 0 |
| Rituximab | 0 |
| Tocilizumab | 0 |
| Vedolizumab | 0 |
IVIG, Intravenous immunoglobulin.